Poor response to rivaroxaban in nephrotic syndrome with acute deep vein thrombosis: A case report

RATIONALE: Hypercoagulability can lead to thromboembolic events that are a life-threatening complication of nephrotic syndrome (NS). Conventional anticoagulants are first-line treatment in the presence of demonstrated thrombosis in NS. Direct-acting oral anticoagulants (DOACs) have provided useful a...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Yan, Chen, Yikuan, Qi, Xiaotong, Hu, Bangqin, Du, Qingqing, Qian, Yan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6709193/
https://www.ncbi.nlm.nih.gov/pubmed/31374026
http://dx.doi.org/10.1097/MD.0000000000016585

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6709193/
https://www.ncbi.nlm.nih.gov/pubmed/31374026
http://dx.doi.org/10.1097/MD.0000000000016585

Ejemplares similares